TransMedics (TMDX) EBITDA Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | -1,147.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,147.00 |
| Dec 31, 2025 | 613.00 |
| Sep 30, 2025 | 1,259.00 |
| Jun 30, 2025 | 1,229.00 |
| Mar 31, 2025 | 629.00 |
| Dec 31, 2024 | 390.00 |
| Sep 30, 2024 | 4,626.00 |
| Jun 30, 2024 | 1,267.00 |
| Mar 31, 2024 | 1,785.00 |
| Dec 31, 2023 | 2,481.00 |
| Sep 30, 2023 | -2,107.00 |
| Jun 30, 2023 | 4,576.00 |
| Mar 31, 2023 | 5,397.00 |
| Dec 31, 2022 | 9,556.00 |
| Sep 30, 2022 | 19,502.00 |
| Jun 30, 2022 | 6,637.00 |
| Mar 31, 2022 | 3,326.00 |
| Dec 31, 2021 | -3,987.00 |
| Sep 30, 2021 | -15,879.00 |
| Jun 30, 2021 | 11,796.00 |
| Mar 31, 2021 | 500.00 |
| Dec 31, 2020 | 6,623.00 |
| Sep 30, 2020 | 4,269.00 |
| Jun 30, 2020 | -9,583.00 |
| Mar 31, 2020 | 3,024.00 |
| Dec 28, 2019 | 3,595.00 |
| Sep 28, 2019 | -299.00 |
| Jun 29, 2019 | 4,089.00 |
| Mar 30, 2019 | 6,230.00 |